Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B- cell lymphomas by Lingchen Fu, Yen-Chiu Lin-Lee,

Slides:



Advertisements
Similar presentations
Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Advertisements

MicroRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia by Daniela Asslaber, Josefina.
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications by Elias Campo, Steven H. Swerdlow, Nancy L.
CD4 T cells: fates, functions, and faults by Jinfang Zhu, and William E. Paul Blood Volume 112(5): September 1, 2008 ©2008 by American Society.
Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes.
Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene by Christof Dame, Karin M. Kirschner, Katharina V. Bartz, Thomas.
EBV-positive diffuse large B-cell lymphoma of the elderly by Chi Young Ok, Thomas G. Papathomas, L. Jeffrey Medeiros, and Ken H. Young Blood Volume 122(3):
Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment by Troy D. Randall, and Irving.
Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells by Shannon A. Keller, Elaine J. Schattner, and Ethel Cesarman Blood.
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
Control of Gene Expression
The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.
Gene therapy: efficient targeting of hematopoietic stem cells
Uncontrolled Wnt signaling causes leukemia
The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells by Changchun.
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
MBL: mostly benign lymphocytes, but…
by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma by Jonathan.
“Vitamin hypothesis”: explanation for allergy increase?
Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.
Adaptive Immunotherapy with Autologous CD25-Depleted and CD3/CD28-Costimulated T-Cells Enhances Lymphocyte Recovery after Cyclophosphamide - Fludarabine.
by James O. Armitage, and Dan L. Longo
An endothelial metronome breast cancer?
Yin and yang of glucocorticoid receptors in apoptosis
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
Juvenile Myelomonocytic Leukemia
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.
Tax fingerprint in adult T-cell leukemia
Nonmyeloablative conditioning for relapsed follicular lymphoma
by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu
An Unusual Cause of Abdominal Pain in Sickle Cell Disease
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.
Telomerase regulation in HTLV-I infection
NFAT control of innate immunity
by Katriina J. Peltola, Kirsi Paukku, Teija L. T
p53 and Apoptosis: It's Not Just in the Nucleus Anymore
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not by Naoko Ishibe, Maher Albitar, Iman.
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience by Daryl Tan, Sandra.
Lymphoma spread? Target CD47-SIRPα!
Vascular endothelial growth factor stimulates protein kinase CβII expression in chronic lymphocytic leukemia cells by Simon T. Abrams, Benjamin R. B. Brown,
by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros
Anergy: the CLL cell limbo
by Bindu Varghese, Adam Widman, James Do, Behnaz Taidi, Debra K
The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia by Christine Le Roy, Pierre-Antoine Deglesne, Nathalie.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
MexT-associated downregulation of oprD expression.
Lan-Hsin Wang, Nicholas E. Baker  Developmental Cell 
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
HoxA9 directly regulates cell cycle control genes.
Fig. 3 Conditionally expressed CAR using Notch as a signal induction and response pathway system. Conditionally expressed CAR using Notch as a signal induction.
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives  Brenda M. Sandmaier, Stephen Mackinnon, Richard.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Anti-CD20-IL-21 fusokine: the tail wags the dog
Influence of the tumor microenvironment on FL
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
NOTCH1 and MYC regulate leukemia cell growth.
A binding relationship with thrombin
Interaction of platelet-decorated VWF strings with leukocytes and infected red blood cells in vitro. Interaction of platelet-decorated VWF strings with.
How I treat early-relapsing follicular lymphoma
Patient Tregs express normal levels of suppression.
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and.
Cold agglutinin disease
Presentation transcript:

Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B- cell lymphomas by Lingchen Fu, Yen-Chiu Lin-Lee, Lan V. Pham, Archito Tamayo, Linda Yoshimura, and Richard J. Ford Blood Volume 107(11): June 1, 2006 ©2006 by American Society of Hematology

BLyS is constitutively expressed in aggressive NHL-B cells. Lingchen Fu et al. Blood 2006;107: ©2006 by American Society of Hematology

Constitutive BLyS expression contributes to NHL-B cell survival in vitro. Lingchen Fu et al. Blood 2006;107: ©2006 by American Society of Hematology

Transcription factors NF-κB and NFAT bind to the BLYS promoter. Lingchen Fu et al. Blood 2006;107: ©2006 by American Society of Hematology

Constitutive BLyS expression through the NF-κB pathway activates a positive feedback loop contributing to NHL-B cell survival. Lingchen Fu et al. Blood 2006;107: ©2006 by American Society of Hematology

Inhibition of NFAT activity reduces BLyS protein expression in NHL-B cells. Lingchen Fu et al. Blood 2006;107: ©2006 by American Society of Hematology

Induction of cellular NF-κB and NFAT activation leads to BLyS protein expression in normal B lymphocytes and low-grade follicular lymphoma (FL) cells. Lingchen Fu et al. Blood 2006;107: ©2006 by American Society of Hematology

Both NF-κB and NFAT binding sites in the BLyS promoter are important for its activity. Lingchen Fu et al. Blood 2006;107: ©2006 by American Society of Hematology